Ragusa, F.; Ferrari, S.M.; Elia, G.; Paparo, S.R.; Balestri, E.; Botrini, C.; Patrizio, A.; Mazzi, V.; Guglielmi, G.; Foddis, R.;
et al. Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer. Int. J. Mol. Sci. 2022, 23, 5731.
https://doi.org/10.3390/ijms23105731
AMA Style
Ragusa F, Ferrari SM, Elia G, Paparo SR, Balestri E, Botrini C, Patrizio A, Mazzi V, Guglielmi G, Foddis R,
et al. Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer. International Journal of Molecular Sciences. 2022; 23(10):5731.
https://doi.org/10.3390/ijms23105731
Chicago/Turabian Style
Ragusa, Francesca, Silvia Martina Ferrari, Giusy Elia, Sabrina Rosaria Paparo, Eugenia Balestri, Chiara Botrini, Armando Patrizio, Valeria Mazzi, Giovanni Guglielmi, Rudy Foddis,
and et al. 2022. "Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer" International Journal of Molecular Sciences 23, no. 10: 5731.
https://doi.org/10.3390/ijms23105731
APA Style
Ragusa, F., Ferrari, S. M., Elia, G., Paparo, S. R., Balestri, E., Botrini, C., Patrizio, A., Mazzi, V., Guglielmi, G., Foddis, R., Spinelli, C., Ulisse, S., Antonelli, A., & Fallahi, P.
(2022). Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer. International Journal of Molecular Sciences, 23(10), 5731.
https://doi.org/10.3390/ijms23105731
